Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Kaiser Permanente’s ALL/PHASE Initiative Wins 2010 Care Continuum Alliance Quality Impact Award for Greatest Impact on Health

October 13, 2010 By Bio-Medicine.Org

OAKLAND, Calif., Oct. 13 /PRNewswire/ — The Care
Continuum Alliance
honored Kaiser Permanente’s ALL/PHASE
initiative with the Quality Impact Award for the “Greatest Impact
on Health” at The Forum 10 conference today in
Washington, D.C.  The ALL/PHASE protocol, which utilizes
low-cost and generic medications and clinical interventions to
reduce heart attacks, has been successfully implemented in Kaiser
Permanente communities, including those served by safety net
organizations.

“Kaiser Permanente’s ALL/PHASE protocol is an outstanding
example of the emphasis on quality embodied by this award,” said
Tracey Moorhead, president and CEO, Care Continuum Alliance. “We’re
pleased to honor this important initiative to improve population
health.”

Kaiser Permanente’s ALL initiative (Aspirin, Lisinopril and
Lipid-lowering medication) was implemented to reduce heart attacks
and strokes by aggressively enrolling patients with heart disease
or patients who are at least 55 years old with diabetes, in a
therapeutic program that included the use of these three
medications. The organization’s PHASE program (Preventing Heart
Attacks and Strokes Everyday) enhances ALL by adding a beta blocker
and emphasizing healthy lifestyle changes. Research has shown that
bundling two low-cost, generic heart drugs – a
cholesterol-lowering statin and a blood pressure-lowering drug
– prevents heart attack and stroke.

Realizing the benefits for its members and community partners,
Kaiser Permanente awarded Community Benefit grants to share this
initiative with safety net clinics. Those grants led to the
implementation of ALL in five community clinics in Southern
California, and the use of PHASE in seven community clinics and
four public hospital and health systems in Northern California.

“The ALL/PHASE initiative continues to be a proven keystone in
Kaiser Permanente’s cardio

‘/>”/>

SOURCE

Related Articles Read More >

Johnson & Johnson Office of Digital Innovation Leader Peter Schulam
Imagining the future of cloud-connected medical devices with Johnson & Johnson leaders
Withings Body Scan
Withings plans launch for Body Scan smart scale platform
BinaxNow COVID-19 Ag Card
Time recognizes Abbott offerings among this year’s 100 best inventions
Koya Medical’s Dayspring device
Koya Medical reports positive early results in Dayspring lymphedema trial

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech